Uihlein Richard E's Form 4 filing
Galectin Therapeutics Inc (GALT) · filed Aug 4, 2026
- Accession no.
- 0001133416-26-000065
- Filed
- Aug 4, 2026, 7:52 AM ET
- Trade date
- Jul 31, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 2 derivative transactions. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Uihlein Richard ECIK 0001694903 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 31, 2026 | Common Stock | MOption exerciseAcquired | +31,825,235 | $3.00 | +$95,475,705 | 42,162,911 | Indirect | |
| Jul 31, 2026 | Common Stock | MOption exerciseAcquired | +2,550,932 | $4.05 | +$10,331,274.6 | 44,713,843 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 31, 2026 | Common Stock | MOption exerciseDisposed | −31,825,235 | $95,475,705.00F1 | – | 0 | Indirect | Price outlier |
| Jul 31, 2026 | Common Stock | MOption exerciseDisposed | −2,550,932 | $10,331,275.00F2 | – | 0 | Indirect | Price outlier |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Consists of $91,000,000 in principal and $14,475,705 in accrued interest.
Referenced by the price of 1 transaction in Table II.
- F2
Consists of $10,000,000 of principal and $331,275 of accrued interest.
Referenced by the price of 1 transaction in Table II.